
Well Health Technologies
(TSX) WELL
Well Health Technologies Financials at a Glance
Market Cap
$996.31M
Revenue (TTM)
$1.40B
Net Income (TTM)
$7.36M
EPS (TTM)
$-0.03
P/E Ratio
-124.60
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$3.90
Volume
733,260
Open
$3.80
Price
$3.90
Volume
733,260
Open
$3.80
Previous Close
$3.90
Daily Range
$3.77 - $3.95
52-Week Range
$3.58 - $6.08
Dividend
$0.00
Beta (Volatility)
1.35 (Average)
Price
$3.90
Volume
733,260
Open
$3.80
Previous Close
$3.90
Daily Range
$3.77 - $3.95
52-Week Range
$3.58 - $6.08
WELL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Well Health Technologies
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
3,200
CEO
Hamed Shahbazi
Website
www.well.companyHeadquarters
Vancouver, BC V6B 5C6, CA
WELL Financials
Key Financial Metrics (TTM)
Gross Margin
38%
Operating Margin
8%
Net Income Margin
-1%
Return on Equity
-85%
Return on Capital
6%
Return on Assets
-0%
Earnings Yield
-0.80%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$996.31M
Shares Outstanding
255.47M
Volume
733.26K
Short Interest
0.00%
Avg. Volume
1.52M
Financials (TTM)
Gross Profit
$525.08M
Operating Income
$113.03M
EBITDA
$206.79M
Operating Cash Flow
$115.79M
Capital Expenditure
$27.87M
Free Cash Flow
$87.92M
Cash & ST Invst.
$133.75M
Total Debt
$710.96M
Well Health Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$384.77M
+99.1%
Gross Profit
$109.62M
+166.3%
Gross Margin
28.49%
N/A
Market Cap
$996.31M
N/A
Market Cap/Employee
$661.12K
N/A
Employees
1,507
N/A
Net Income
$22.89M
+276.0%
EBITDA
$61.55M
+422.0%
Quarterly Fundamentals
Net Cash
$577.21M
-96.7%
Accounts Receivable
$202.63M
+1.0%
Inventory
$2.46M
-8.4%
Long Term Debt
$601.34M
+51.5%
Short Term Debt
$109.62M
+291.0%
Return on Assets
-0.35%
N/A
Return on Invested Capital
6.50%
N/A
Free Cash Flow
$34.14M
+131.5%
Operating Cash Flow
$42.62M
+141.5%